SCOTTSDALE, Ariz., March 31, 2006 (PRIMEZONE) -- Motion DNA Corporation (Pink Sheets:MTDX) today announced its campaign to distribute copies and grant free licenses to its brand new, patented "BioResearch 3-D" software to medical and academic research institutions.
BioResearch 3-D utilizes existing motion-capture hardware systems, which come with basic software; however, with Motion DNA's unparalleled, universally adaptable software, these institutions will now operate much more efficiently, accurately and save valuable time and money. Currently, medical and research institutions pay between $10,000 and $15,000 for biomechanics software.
Motion DNA estimates that there are more than 10,000 academic institutions and hospitals, in the public and private sectors, which currently use some form of motion-capture hardware and software for research purposes. This list includes UCLA Medical Center, The Mayo Clinic, The Cleveland Clinic, Barrow Neurological Institute, hundreds of children's hospitals and university academic programs around the world.
"We are delighted to be able to contribute to the efficiency of these clinical and academic research facilities for the benefit of science," said Zig Ziegler, Founder and current CEO of Motion DNA Corporation. "These institutions are at the forefront of major scientific discoveries, which can help Motion DNA testing to become a significant contributor to medical academia. And, as these institutions are developing the physical medicine leaders of tomorrow, by releasing a research version of our software, which has the full capabilities of our technology, we expect tomorrow's leaders to graduate completely prepared to deliver the absolute best intervention methods related to human movement."
The MTDX BioResearch 3-D package includes real-time motion capture and data analysis, sophisticated mathematics calculations, and dozens of motion-related protocols. Qualified research institutions are those who fall into one of the categories mentioned above, and are asked to submit their request to info@motiondnacorp.com giving information about their program, including the hardware they currently utilize.
Only 200 institutions will be granted Motion DNA's BioResearch 3-D Software. The free copies of BioResearch 3-D are limited to those institutions who submit their requests by June 1, 2006.
About Motion DNA Corporation
Based in Scottsdale, Ariz., Motion DNA has developed state-of-art products and services that incorporate advanced 3-D motion-capture technology, which provides diagnostic testing for individual athletes, medical professionals and sports organizations. These types of analyses are designed to identify physical limitations related to strength, mobility, coordination and biomechanics.
The Motion DNA Corporation logo is available at: http://www.primezone.com/newsroom/prs/?pkgid=2484
Forward-Looking Statements:
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications that may arise could prevent the prompt implementation of any strategically significant plan(s) outlined above. The company cautions that these forward-looking statements are further qualified by other factors. The company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise.